These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15680414)

  • 21. Ig-binding receptors on human NK cells as effector and regulatory surface molecules.
    Sulica A; Morel P; Metes D; Herberman RB
    Int Rev Immunol; 2001 Jun; 20(3-4):371-414. PubMed ID: 11878510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of direct and indirect forms of anti-HIV-1 ADCC: implications for other retroviral disease.
    Weinhold KJ; Tyler DS; Lyerly HK
    Dev Biol Stand; 1990; 72():343-8. PubMed ID: 2282991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells.
    Kellner C; Bruenke J; Stieglmaier J; Schwemmlein M; Schwenkert M; Singer H; Mentz K; Peipp M; Lang P; Oduncu F; Stockmeyer B; Fey GH
    J Immunother; 2008; 31(9):871-84. PubMed ID: 18833000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterodimeric bispecific antibody-derivatives against CD19 and CD16 induce effective antibody-dependent cellular cytotoxicity against B-lymphoid tumor cells.
    Kellner C; Bruenke J; Horner H; Schubert J; Schwenkert M; Mentz K; Barbin K; Stein C; Peipp M; Stockmeyer B; Fey GH
    Cancer Lett; 2011 Apr; 303(2):128-39. PubMed ID: 21339041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.
    Patankar MS; Jing Y; Morrison JC; Belisle JA; Lattanzio FA; Deng Y; Wong NK; Morris HR; Dell A; Clark GF
    Gynecol Oncol; 2005 Dec; 99(3):704-13. PubMed ID: 16126266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells.
    Zhang T; Li Y; Wang YJ; Wang X; Young M; Douglas SD; Ho WZ
    Antiviral Res; 2007 Feb; 73(2):132-9. PubMed ID: 16997390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC class I-related chain A conjugated to antitumor antibodies can sensitize tumor cells to specific lysis by natural killer cells.
    Germain C; Larbouret C; Cesson V; Donda A; Held W; Mach JP; Pèlegrin A; Robert B
    Clin Cancer Res; 2005 Oct; 11(20):7516-22. PubMed ID: 16243826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted cellular therapy with natural killer cells.
    Klingemann H; Boissel L
    Horm Metab Res; 2008 Feb; 40(2):122-5. PubMed ID: 18283630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC).
    Cox JH
    Methods Mol Med; 1999; 17():373-81. PubMed ID: 21380688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
    Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
    Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent ineffectiveness of natural killer cells vis-à-vis retrovirus-infected targets.
    Zheng ZY; Zucker-Franklin D
    J Immunol; 1992 Jun; 148(11):3679-85. PubMed ID: 1350295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent function.
    Dutertre CA; Bonnin-Gélizé E; Pulford K; Bourel D; Fridman WH; Teillaud JL
    J Leukoc Biol; 2008 Dec; 84(6):1511-20. PubMed ID: 18719017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
    Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
    Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.
    Dall'Ozzo S; Tartas S; Paintaud G; Cartron G; Colombat P; Bardos P; Watier H; Thibault G
    Cancer Res; 2004 Jul; 64(13):4664-9. PubMed ID: 15231679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD16 polymorphisms and NK activation induced by monoclonal antibody-coated target cells.
    Bowles JA; Weiner GJ
    J Immunol Methods; 2005 Sep; 304(1-2):88-99. PubMed ID: 16109421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32).
    Bhatnagar N; Ahmad F; Hong HS; Eberhard J; Lu IN; Ballmaier M; Schmidt RE; Jacobs R; Meyer-Olson D
    Eur J Immunol; 2014 Nov; 44(11):3368-79. PubMed ID: 25100508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1.
    Harada H; Goto Y; Ohno T; Suzu S; Okada S
    Eur J Immunol; 2007 Aug; 37(8):2148-55. PubMed ID: 17628860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.